Summary:
Currently, an international clinical research study (CAIN 457F2305) is under way to evaluate the safety and effectiveness of an investigational drug for people living with active Ankylosing Spondylitis (AS) every day.
Qualified Participants Must:
• Be at least 18 years of age
•
Have a confirmed diagnosis of Ankylosing Spondylitis
Qualified Participants May Receive:
Study-related health examinations at no cost and study related medication and care at no cost. Other eligibility criteria will apply and insurance is not required. Compensation for time and travel up to $1,775.